1. Anand R, Hartman R, Hayes P, and Gharabawi M (1996): An overview of the development of SDZ ENA 713, a brain selective Cholinesterase inhibitor. In: Alzheimer Disease: from Molecular Biology to Therapy. Becker R and Giacobini E, eds. Boston:Birkhauser.
2. Bartels CF, Moriearty PL, Becker RE, Mountjoy CP and Lockridge O (1994): Acetylcholinesterase gene sequence and copy number are normal in Alzheimer’s disease patients treated with the organophosphate metrifonate. Proceedings, Fifth International Symposium on Cholinesterases, Madras, India.
3. Becker R (1991): Therapy of the cognitive deficit in Alzheimer’s disease: The cholinergic system. In: Cholinergic Basis for Alzheimer Therapy. Becker R and Giacobini E, eds. Boston, Birkhauser.
4. Becker R and Giacobini E (1988a): Advances in the therapy of Alzheimer’s disease: Issues in the study and development of cholinomimetic therapies. In: Current Research in Alzheimer Therapy. Giacobini E and Becker R, eds. New York: Taylor and Francis.
5. Becker R and Giacobini E (1988b): Mechanisms of Cholinesterase inhibition in senile dementia of the Alzheimer type. Drug Dev Res 12:163–195.